« Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis ». One Health & Risk Management , vol. 6, nᵒ 3, septembre 2025, p. 44-53, https://doi.org/10.38045/ohrm.2025.3.04.